Dec. 12, 2012
/PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Drug Delivery: Surveying the Global Competitive Landscape
The importance of drug delivery technology grows ever more acute; commercial and industry interest is continuing to build. The benefits to patients can be seen in improved medical outcomes, while the pharmaceutical industry is able to extend patent protection through novel delivery regimes, bringing new therapies to the market that would, previously, have been impossible to administer.
This new, richly-detailed report provides the most comprehensive review of the sector and examines the competitive drug delivery landscape with analysis of 112 key companies. The company landscape is always on the move: some have been bought by the big players, whilst others have just run out of money and gone to the wall. Slowly but surely the private equity groups - most of whom have been in relative hibernation for the past couple of years - are gradually returning to the fold and kick-starting the impetus for capital investment.
This report provides you with key data for each featured company...
Company Overview & Technology Focus
Competition & Competing Products
R&D & Research Strategy
Key Agreements & Alliances
Financial Data (where available)
Comprehensive Contact Details
The ability to readily assess the companies involved, research areas of interest, products being developed, strategic collaborations and performance is key to understanding this market. In 670+ information-packed pages, this new report Drug Delivery: Surveying the global competitive landscape 2012 (published
) evaluates companies large and small from multinationals to specialist development and technology businesses. All major technology areas such as Controlled-release, Nucleic acid, Nano-enabled and Targeted delivery are covered.